Showing results (131-140 of 251) with videos related to

Sort By:
Pageof 26
British Journal of Cancer|April 14, 2015
Combining bevacizumab and chemoradiation in rectal cancer. Translational results of the AXEBeam trialM Verstraete, A Debucquoy, J Dekervel, et al.
Acta Gastro-Enterologica Belgica|May 1, 2009
Quality assurance and recommendations for quality assessment of screening colonoscopy in BelgiumE Macken, T Moreels, P Pelckmans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 28, 2014
Quality assurance in the treatment of colorectal cancer: the EURECCA initiativeA J Breugom, P G Boelens, C B M van den Broek, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 14, 2017
Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trialsD Arnold, B Lueza, J-Y Douillard, et al.
ESMO Open|June 10, 2022
Effect of KRAS codon 12 or 13 mutations on survival with trifluridine/tipiracil in pretreated metastatic colorectal cancer: a meta-analysisT Yoshino, E Van Cutsem, J Li, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2002
Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancerP Flamen, E Van Cutsem, A Lerut, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2015
A phase I/II, open-label, randomised study of nintedanib plus mFOLFOX6 versus bevacizumab plus mFOLFOX6 in first-line metastatic colorectal cancer patientsE Van Cutsem, H Prenen, G D'Haens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 21, 2017
Cabozantinib in hepatocellular carcinoma: results of a phase 2 placebo-controlled randomized discontinuation studyR K Kelley, C Verslype, A L Cohn, et al.
European Journal of Cancer (Oxford, England : 1990)|September 30, 2004
Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancerJ M Blazeby, T Conroy, A Bottomley, et al.
British Journal of Cancer|March 10, 2005
Optimisation of irinotecan dose in the treatment of patients with metastatic colorectal cancer after 5-FU failure: results from a multinational, randomised phase II studyE Van Cutsem, L Dirix, J-L Van Laethem, et al.
Pageof 26